TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 133 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $42,816,000 | -33.8% | 1,600,000 | -51.8% | 3.85% | -25.5% |
Q2 2020 | $64,689,000 | +84.9% | 3,320,808 | -6.6% | 5.17% | +41.4% |
Q1 2020 | $34,994,000 | -42.0% | 3,556,324 | -34.6% | 3.66% | -30.4% |
Q4 2019 | $60,326,000 | +390.5% | 5,434,783 | +81.2% | 5.25% | +237.8% |
Q4 2018 | $12,300,000 | +12.6% | 3,000,000 | +53.8% | 1.56% | -8.6% |
Q3 2018 | $10,920,000 | – | 1,950,000 | – | 1.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |